Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer
{{output}}
One of the leading causes of death related to cancer worldwide is non-small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) mutations are one of the most important therapeutic targets. Lazertinib is an irreversible EGFR tyrosine kinase inhibi... ...
